Skip to main content

Table 3 Correlation between pCR and clinical-pathological data: multivariate analysis

From: Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective study

pCR

OR

95% CI

p

Age

  < 50

   

  ≥ 50

0.45

0.3–0.7

0.001

Clinical stage

 I-II

   

 III

0.34

0.2–0.6

0.0001

Histological grade (SBR)

 II

   

 III

1.19

0.7–1.9

0.5

Tumor subtypes

 HER2+

1.6

0.7–3.8

0.2

 HR+/Her2-

   

 TNBC

1.0

0.5–2.3

0.9

VD level

  < 20 ng/mL

   

  ≥ 20 ng/mL

0.43

0.2–0.8

0.01